Biallelic variants in EFEMP1 in a man with a pronounced connective tissue phenotype

Abstract

Connective tissue disorders are a spectrum of diseases that affect the integrity of tissues including skin, vasculature, and joints. They are often caused by variants that disrupt genes encoding components of extracellular matrix (ECM). The fibulin glycoproteins are ECM proteins important for integrity of tissues including dermis, retina, fascia, and vasculature. The fibulin family consists of seven members (fibulins-1 to -7) and is defined by a fibulin-type domain at the C-terminus. The family is associated with human diseases, for instance a variant in FBLN1, encoding fibulin-1, is associated with synpolydactyly, while one in EFEMP1, encoding fibulin-3, causes Doyne honeycomb degeneration of the retina. Loss-of-function of fibulins-4 and -5 causes cutis laxa, while variants in fibulins-5 and -6 are associated with age-related macular degeneration. Of note, EFEMP1 is not currently associated with any connective tissue disorder. Here we show biallelic loss-of-function variants in EFEMP1 in an individual with multiple and recurrent abdominal and thoracic herniae, myopia, hypermobile joints, scoliosis, and thin translucent skin. Fibroblasts from this individual express significantly lower EFEMP1 transcript than age-matched control cells. A skin biopsy, visualised using light microscopy, showed normal structure and abundance of elastic fibres. The phenotype of this individual is remarkably similar to the Efemp1 knockout mouse model that displays multiple herniae with premature aging and scoliosis. We conclude that loss of EFEMP1 function in this individual is the cause of a connective tissue disorder with a novel combination of phenotypic features, and can perhaps explain similar, previously reported cases in the literature.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1
Fig. 2

References

  1. 1.

    Milewicz DM, Pyeritz RE, Crawford ES, Byers PH. Marfan syndrome: defective synthesis, secretion, and extracellular matrix formation of fibrillin by cultured dermal fibroblasts. J Clin Investig. 1992;89:79–86.

  2. 2.

    Dietz HC, Cutting CR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature. 1991;352:337–9.

  3. 3.

    Beighton P, Paepe AD, Steinmann B, Tsipouras P, Wenstrup RJ. Ehlers-Danlos syndromes: revised nosology. Am J Med Genet. 1998;77:31–37.

  4. 4.

    Malfait F, de Paepe A. Molecular genetics in classic Ehlers–Danlos syndrome. Am J Med Genet Part C Semin Med Genet. 2005;139C:17–23.

  5. 5.

    Pepin M, Schwarze U, Superti-Furga A, Byers PH. Clinical and genetic features of Ehlers–Danlos syndrome type IV, the vascular type. N Engl J Med. 2000;342:673–80.

  6. 6.

    Chu M-L, Tsuda T. Fibulins in development and heritable disease. Birth Defects Res Part C Embryo Today Rev. 2004;72:25–36.

  7. 7.

    Kobayashi N, Kostka G, Garbe JHO, Keene DR, Bächinger HP, Hanisch F-G, et al. A comparative analysis of the fibulin protein family: biochemical characterization, binding interactions, and tissue localization. J Biol Chem. 2007;282:11805–16.

  8. 8.

    de Vega S, Iwamoto T, Yamada Y. Fibulins: multiple roles in matrix structures and tissue functions. Cell Mol Life Sci. 2009;66:1890–902.

  9. 9.

    Zhang H-Y, Timpl R, Sasaki T, Chu M-L, Ekblom P. Fibulin-1 and fibulin-2 expression during organogenesis in the developing mouse embryo. Dev Dyn. 1996;205:348–64.

  10. 10.

    Cooley MA, Kern CB, Fresco VM, Wessels A, Thompson RP, McQuinn TC, et al. Fibulin-1 is required for morphogenesis of neural crest-derived structures. Dev Biol. 2008;319:336–45.

  11. 11.

    Sicot F-X, Tsuda T, Markova D, Klement JF, Arita M, Zhang R-Z, et al. Fibulin-2 Is dispensable for mouse development and elastic fiber formation. Mol Cell Biol. 2008;28:1061–7.

  12. 12.

    Debeer P, Schoenmakers EFPM, Twal WO, Argraves WS, De Smet L, Fryns JP, et al. The fibulin-1 gene (FBLN1) is disrupted in a t(12;22) associated with a complex type of synpolydactyly. J Med Genet. 2002;39:98–104.

  13. 13.

    Hucthagowder V, Sausgruber N, Kim KH, Angle B, Marmorstein LY, Urban Z. Fibulin-4: a novel gene for an autosomal recessive cutis laxa syndrome. Am J Hum Genet. 2006;78:1075–80.

  14. 14.

    Markova D, Zou Y, Ringpfeil F, Sasaki T, Kostka G, Timpl R, et al. Genetic heterogeneity of cutis laxa: a heterozygous tandem duplication within the fibulin-5 (FBLN5) gene. Am J Hum Genet. 2003;72:998–1004.

  15. 15.

    Lotery AJ, Baas D, Ridley C, Jones RPO, Klaver CCW, Stone E, et al. Reduced secretion of fibulin 5 in age-related macular degeneration and cutis laxa. Hum Mutat. 2006;27:568–74.

  16. 16.

    Stone EM, Braun TA, Russell SR, Kuehn MH, Lotery AJ, Moore PA, et al. Missense variations in the fibulin 5 gene and age-related macular degeneration. N. Engl J Med. 2004;351:346–53.

  17. 17.

    Schultz DW, Mahan A, Humpert AJ, Runckel C, Luzier CW, Cassera M, et al. Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family. Hum Mol Genet. 2003;12:3315–23.

  18. 18.

    Zhang Y, Marmorstein LY. Focus on molecules: fibulin-3 (EFEMP1). Exp eye Res. 2010;90:374–5.

  19. 19.

    McLaughlin PJ, Bakall B, Marmorstein AD, Marmorstein LY, Liu Z, Davis EC, et al. Lack of fibulin-3 causes early aging and herniation, but not macular degeneration in mice. Hum Mol Genet. 2007;16:3059–70.

  20. 20.

    Stone EM, Lotery AJ, Munier FL, Héon E, Piguet B, Guymer RH, et al. A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet. 1999;22:199–202.

  21. 21.

    Lecka-Czernik B, Lumpkin CK, Goldstein S. An overexpressed gene transcript in senescent and quiescent human fibroblasts encoding a novel protein in the epidermal growth factor-like repeat family stimulates DNA synthesis. Mol Cell Biol. 1995;15:120–8.

  22. 22.

    McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis toolkit: a mapreduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297–303.

  23. 23.

    DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011;43:491-8.

  24. 24.

    Li H, Durbin R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics. 2009;25:1754–60.

  25. 25.

    Van der Auwera G, Carneiro M, Hartl C, Poplin R, del Angel G, Levy-Moonshine A, et al. From FastQ data to high-confidence variant calls: the genome analysis toolkit best practices pipeline. Curr Protoc Bioinform. 2013;43:11.10.11–11.10.33.

  26. 26.

    Cingolani P, Platts A, Wang LL, Coon M, Nguyen T, Wang L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly. 2012;6:80–92.

  27. 27.

    Exome Aggregation Consortium. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2015;536:285–91.

  28. 28.

    Hasegawa A, Yonezawa T, Taniguchi N, Otabe K, Akasaki Y, Matsukawa T, et al. Role of fibulin 3 in aging-related joint changes and osteoarthritis pathogenesis in human and mouse knee cartilage. Arthritis Rheumatol. 2017;69:576–85.

  29. 29.

    Klenotic PA, Munier FL, Marmorstein LY, Anand-Apte B. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a binding partner of epithelial growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1): implications for macular degenerations. J Biol Chem. 2004;279:30469–73.

  30. 30.

    de Silva H, Gunawardena T, Law F. Unusual complications in siblings with marfanoid phenotype. Arch Dis Child. 1996;75:247–8.

  31. 31.

    Clunie G, Mason J. Visceral diverticula and the Marfan syndrome. Br J Surg. 1962;50:51–52.

  32. 32.

    Urban Z, Hucthagowder V, Schürmann N, Todorovic V, Zilberberg L, Choi J, et al. Mutations in LTBP4 cause a syndrome of impaired pulmonary, gastrointestinal, genitourinary, musculoskeletal, and dermal development. Am J Hum Genet. 2009;85:593–605.

  33. 33.

    Hbibi M, Abourazzak S, Idrissi M, Chaouki S, Atmani S, Hida M. Cutis Laxa syndrome: a case report. Pan Afr Med J. 2015;20:3–3.

Download references

Acknowledgements

We would like to thank the proband and his family for their agreement to participate in this study, the Histology Department at the University of Otago for technical assistance, Sam Hawarden for his contribution to the whole-exome analysis, and Curekids NZ for funding.

Author information

Correspondence to Stephen P. Robertson.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Driver, S.G.W., Jackson, M.R., Richter, K. et al. Biallelic variants in EFEMP1 in a man with a pronounced connective tissue phenotype. Eur J Hum Genet (2019). https://doi.org/10.1038/s41431-019-0546-7

Download citation

Further reading